d-alpha tocopherol has been researched along with dihydropyridines in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diumaev, KM; Smirnov, LD | 1 |
| Locher, R; Lupo, E; Vetter, W; Weisser, B | 1 |
| Bianchi, A; Capizzi, RL; Capuzzi, DM; D'Armiento, FP; de Nigris, F; Donzelli, R; Godfraind, T; Gonnella, JS; Mancini, M; Napoli, C; Palinski, W; Palumbo, G; Salomone, S | 1 |
| Sevanian, A; Shen, L; Ursini, F | 1 |
| Camargo, C; López-Alarcón, C; Navarrete, P; Núñez-Vergara, LJ; Squella, JA | 1 |
| Campagnola, M; Cominacini, L; Cristofori, P; Crivellente, F; Faustinelli, I; Garbin, U; Pasini, AF; Rigoni, A; Tosetti, M; Turton, J | 1 |
| Fujitani, Y; Hirose, T; Kanazawa, A; Kawamori, R; Ohmura, C; Sakai, K; Shimizu, T; Uchino, H; Watada, H | 1 |
| Baek, IH; Cho, W; Choo, GH; Ha, ES; Hwang, SJ; Jin, SE; Jung, YS; Kim, JS; Kim, MS | 1 |
| Chamsai, B; Limmatvapirat, S; Sriamornsak, P; Sungthongjeen, S | 1 |
1 review(s) available for d-alpha tocopherol and dihydropyridines
| Article | Year |
|---|---|
[Current trends in the search for membrane-active compounds and membrane-active compound-based drugs].
Topics: Antioxidants; Antiviral Agents; Cardiovascular Agents; Cell Membrane Permeability; Dihydropyridines; Flavonoids; Pharmacology; Phenols; Polymers; Polyphenols; Psychotropic Drugs; Pyridines; Pyrimidines; Research; Vitamin E | 1984 |
1 trial(s) available for d-alpha tocopherol and dihydropyridines
| Article | Year |
|---|---|
Calcium channel blocker, azelnidipine, reduces lipid hydroperoxides in patients with type 2 diabetes independent of blood pressure.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Ascorbic Acid; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Erythrocytes; Female; Humans; Hypertension; Lipid Peroxides; Male; Middle Aged; Organophosphorus Compounds; Pyrenes; Vitamin E | 2007 |
7 other study(ies) available for d-alpha tocopherol and dihydropyridines
| Article | Year |
|---|---|
In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.
Topics: Adult; Amlodipine; Antioxidants; Calcium Channel Blockers; Copper; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Humans; Isradipine; Lipoproteins, LDL; Oxidation-Reduction; Reference Values; Thiobarbituric Acid Reactive Substances; Verapamil; Vitamin E | 1994 |
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Antioxidants; Apolipoproteins B; Arteries; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Epitopes; Genetic Predisposition to Disease; Immunohistochemistry; Lipoproteins, LDL; Male; Oxidation-Reduction; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reference Values; Vitamin E | 1999 |
Inhibition of LDL oxidation and oxidized LDL-induced cytotoxicity by dihydropyridine calcium antagonists.
Topics: Animals; Antioxidants; Ascorbic Acid; Calcium; Calcium Channel Blockers; Cell Survival; Cells, Cultured; Dihydropyridines; Endothelium, Vascular; Fluorescent Dyes; Kinetics; Lipid Peroxidation; Lipoproteins, LDL; Oxidation-Reduction; Rabbits; Reactive Oxygen Species; Vitamin E | 2000 |
Reactivity of 1,4-dihydropyridines toward alkyl, alkylperoxyl radicals, and ABTS radical cation.
Topics: Benzothiazoles; Cations; Chromans; Dihydropyridines; Free Radical Scavengers; Free Radicals; Gas Chromatography-Mass Spectrometry; Hydrogen-Ion Concentration; Kinetics; Nisoldipine; Peroxides; Spectrophotometry, Ultraviolet; Sulfonic Acids; Vitamin E | 2003 |
Reduced progression of atherosclerosis in apolipoprotein E-deficient mice treated with lacidipine is associated with a decreased susceptibility of low-density lipoprotein to oxidation.
Topics: Animals; Antioxidants; Apolipoproteins E; Arteriosclerosis; Calcium Channel Blockers; Dihydropyridines; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Lipid Peroxidation; Lipoproteins, LDL; Malondialdehyde; Mice; Mice, Knockout; Random Allocation; Vitamin E | 2004 |
Dissolution and bioavailability of lercanidipine-hydroxypropylmethyl cellulose nanoparticles with surfactant.
Topics: Administration, Oral; Biological Availability; Dihydropyridines; Drug Compounding; Humans; Hypromellose Derivatives; Nanoparticles; Particle Size; Poloxamer; Polyethylene Glycols; Solubility; Vitamin E | 2015 |
Enhancement of solubility and oral bioavailability of manidipine by formation of ternary solid dispersion with d-α-tocopherol polyethylene glycol 1000 succinate and copovidone.
Topics: alpha-Tocopherol; Animals; Biological Availability; Calorimetry, Differential Scanning; Dihydropyridines; Nitrobenzenes; Piperazines; Polyethylene Glycols; Powders; Pyrrolidines; Rats; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; Succinates; Vinyl Compounds; X-Ray Diffraction | 2017 |